NCT02573376View on ClinicalTrials.gov

Antiviral Pharmacology and Adherence in Drug Users

NACompletedINTERVENTIONAL
Enrollment

73

Participants

Timeline

Start Date

November 30, 2015

Primary Completion Date

March 31, 2020

Study Completion Date

June 30, 2021

Conditions
HEPATITIS CVirus, Human Immunodeficiency
Interventions
BEHAVIORAL

Directly Observed Therapy

BEHAVIORAL

Wirelessly Observed Therapy

Trial Locations (1)

80045

University of Colorado Anschutz Medical Campus, Aurora

Sponsors

Collaborators (1)

Gilead Sciences
All Listed Sponsors
collaborator

Denver Health and Hospital Authority

OTHER

collaborator

National Institute on Drug Abuse (NIDA)

NIH

collaborator

Gilead Sciences

INDUSTRY

lead

University of Colorado, Denver

OTHER

NCT02573376 - Antiviral Pharmacology and Adherence in Drug Users | Biotech Hunter | Biotech Hunter